Catalyst Wire Dossier Catalyst Wire Dossier

I.V.-Hepabig Inj.

· GC Biopharma Corp
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for I.V.-Hepabig Inj., covering 2025-06-25 to 2025-06-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate the Safety and Efficacy of Undiluted Intravenous Infusion of I.V.-Hepabig Inj. [Phase 3]

See pricing